BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 28554319)

  • 1. Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives.
    Jurgens S; Kuhn FE; Casini A
    Curr Med Chem; 2018 Feb; 25(4):437-461. PubMed ID: 28554319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclometalated Gold(III) Complexes Bearing DACH Ligands.
    Gukathasan S; Parkin S; Awuah SG
    Inorg Chem; 2019 Jul; 58(14):9326-9340. PubMed ID: 31247820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Variations on the Theme of Gold(III) C
    Carboni S; Zucca A; Stoccoro S; Maiore L; Arca M; Ortu F; Artner C; Keppler BK; Meier-Menches SM; Casini A; Cinellu MA
    Inorg Chem; 2018 Dec; 57(23):14852-14865. PubMed ID: 30457328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic Insights into Gold Organometallic Compounds and their Biomedical Applications.
    Jürgens S; Casini A
    Chimia (Aarau); 2017 Mar; 71(3):92-101. PubMed ID: 28351454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicinal Chemistry of Gold Anticancer Metallodrugs.
    Casini A; Sun RW; Ott I
    Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action.
    Casini A; Hartinger C; Gabbiani C; Mini E; Dyson PJ; Keppler BK; Messori L
    J Inorg Biochem; 2008 Mar; 102(3):564-75. PubMed ID: 18177942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative biological evaluation and G-quadruplex interaction studies of two new families of organometallic gold(I) complexes featuring N-heterocyclic carbene and alkynyl ligands.
    Meier-Menches SM; Aikman B; Döllerer D; Klooster WT; Coles SJ; Santi N; Luk L; Casini A; Bonsignore R
    J Inorg Biochem; 2020 Jan; 202():110844. PubMed ID: 31739113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights in Au-NHCs complexes as anticancer agents.
    Porchia M; Pellei M; Marinelli M; Tisato F; Del Bello F; Santini C
    Eur J Med Chem; 2018 Feb; 146():709-746. PubMed ID: 29407992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds.
    Bertrand B; Casini A
    Dalton Trans; 2014 Mar; 43(11):4209-19. PubMed ID: 24225667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
    Ma DL; Chan DS; Leung CH
    Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
    Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
    Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond platinums: gold complexes as anticancer agents.
    Nardon C; Boscutti G; Fregona D
    Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical biology of anticancer gold(III) and gold(I) complexes.
    Zou T; Lum CT; Lok CN; Zhang JJ; Che CM
    Chem Soc Rev; 2015 Dec; 44(24):8786-801. PubMed ID: 25868756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
    Kovala-Demertzi D; Papageorgiou A; Papathanasis L; Alexandratos A; Dalezis P; Miller JR; Demertzis MA
    Eur J Med Chem; 2009 Mar; 44(3):1296-302. PubMed ID: 18848372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
    Li CK; Sun RW; Kui SC; Zhu N; Che CM
    Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold coordination complexes as anticancer agents.
    Kostova I
    Anticancer Agents Med Chem; 2006 Jan; 6(1):19-32. PubMed ID: 16475924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and quantum-chemical studies of 1H, 13C and 15N NMR coordination shifts in Au(III), Pd(II) and Pt(II) chloride complexes with picolines.
    Pazderski L; Tousek J; Sitkowski J; Malináková K; Kozerski L; Szłyk E
    Magn Reson Chem; 2009 Mar; 47(3):228-38. PubMed ID: 19097135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties.
    Frik M; Fernández-Gallardo J; Gonzalo O; Mangas-Sanjuan V; González-Alvarez M; Serrano del Valle A; Hu C; González-Alvarez I; Bermejo M; Marzo I; Contel M
    J Med Chem; 2015 Aug; 58(15):5825-41. PubMed ID: 26147404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold(III) complexes in medicinal chemistry.
    Maia PI; Deflon VM; Abram U
    Future Med Chem; 2014 Sep; 6(13):1515-36. PubMed ID: 25365235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel metals and metal complexes as platforms for cancer therapy.
    Frezza M; Hindo S; Chen D; Davenport A; Schmitt S; Tomco D; Dou QP
    Curr Pharm Des; 2010 Jun; 16(16):1813-25. PubMed ID: 20337575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.